Best Options Strategy for RGNX
Looking for the best options strategy for REGENXBIO Inc. (RGNX)? There is no single answer — the right play depends on your outlook, your risk tolerance and current implied volatility. Below, our free engine shows the highest-scoring defined-risk strategy on the live RGNX option chain right now, and a simple map from your view on RGNX to the strategy that fits it. Model any of them in the calculator before you trade.
About REGENXBIO Inc.
REGENXBIO Inc. is a biotechnology company developing gene therapies designed to correct genetic disorders by delivering functional genes to defective cells. The company's pipeline relies on NAV Technology Platform, a proprietary system using adeno-associated viruses to carry genetic material into target tissues. Its clinical candidates address serious conditions including wet age-related macular degeneration and diabetic retinopathy through ABBV-RGX-314, Duchenne muscular dystrophy via RGX-202, and two forms of mucopolysaccharidosis through RGX-121 and RGX-111. Beyond developing its own products, the company generates revenue by licensing the NAV platform to other pharmaceutical firms and biotechnology companies seeking to build their own gene therapy programs.
The company operates primarily through product development and platform licensing agreements. Its most advanced partnership involves AbbVie, which is advancing ABBV-RGX-314 in clinical trials. REGENXBIO has also partnered with Nippon Shinyaku to commercialize RGX-121 and RGX-111 outside the United States, expanding its geographic reach through these arrangements. Founded in 2008 and based in Rockville, Maryland, the…
Today's top-scoring strategy for RGNX
Our engine ranks defined-risk strategies on the live RGNX chain by probability of profit and risk/reward, then surfaces the best-scoring one. It is an educational illustration, not advice.
| Action | Qty | Type | Strike | Premium |
|---|---|---|---|---|
| Buy | 1× | PUT | $5 | $0.25 |
| Sell | 1× | PUT | $10 | $1.30 |
| Sell | 1× | CALL | $10 | $1.48 |
| Buy | 1× | CALL | $17 | $0.30 |
Simulazione
Simulazione prospettica di 6,000 traiettorie di prezzo lognormali fino alla scadenza — non è un backtest storico.
Analisi della strategia
Greche vs prezzo
Prezzo × volatilità (oggi)
| −30% | −15% | IV | +15% | +30% | |
|---|---|---|---|---|---|
| $13 | −$74 | −$86 | −$100 | −$113 | −$126 |
| $12 | −$42 | −$62 | −$80 | −$98 | −$114 |
| $12 | −$14 | −$39 | −$62 | −$84 | −$103 |
| $11 | $10 | −$20 | −$47 | −$72 | −$93 |
| $11 | $28 | −$5 | −$36 | −$62 | −$86 |
| $10 | $39 | $4 | −$28 | −$56 | −$81 |
| $10 | $42 | $7 | −$25 | −$54 | −$79 |
| $9 | $37 | $3 | −$27 | −$55 | −$79 |
| $9 | $21 | −$7 | −$35 | −$61 | −$84 |
| $8 | −$3 | −$26 | −$49 | −$71 | −$92 |
| $8 | −$34 | −$51 | −$68 | −$86 | −$103 |
Live scan from 2026-07-21 · quotes delayed ~15 minutes
Backtest storico: come si sarebbe comportata una Iron Butterfly su RGNX
Abbiamo simulato in modo approssimativo una Iron Butterfly su RGNX che avresti aperto ripetutamente nell'ultimo anno (92 ingressi storici, ciascuno mantenuto fino alla scadenza), con i premi d'ingresso modellati tramite Black-Scholes. Ecco come sarebbe andata sulla reale storia dei prezzi di RGNX — un backtest didattico, non una previsione dei rendimenti futuri.
In via approssimativa: i premi d'ingresso sono modellati con Black-Scholes sulla base della volatilità realizzata trailing, mantenuti fino alla scadenza e regolati contro il reale prezzo di chiusura storico. Fill reali, volatilità implicita e slippage differiscono — consideralo come contesto indicativo, non come rendimento esatto.
Implied volatility
RGNX is currently trading with high implied volatility, which makes its options expensive — and attractive to sell. On the options we scanned that was around 113% implied volatility, and higher implied volatility means richer premiums and wider expected moves.
Options on RGNX currently price in about 113% implied volatility, versus roughly 109% the stock has actually realised over the past month. The two are roughly in line, so neither buying nor selling premium has a clear volatility edge here.
Off that volatility, the options market is pricing a move of about ±$3,33 (±33%) in RGNX by 2026-08-21 — a range of roughly $6,87 to $13,53. Strikes inside that band hold most of the premium and see most of the action.
In evidenza dalla option chain di RGNX: open interest, volume e skew
La option chain live di RGNX mostra un rapporto put/call sull'open interest di 0.46 (bullish-leaning (more calls)), con una volatilità implicita at-the-money intorno al 103.9%. L'open interest si concentra sulla call a 12 — un classico "muro" di resistenza — e sulla put a 8, un "muro" di supporto: esattamente gli strike a cui gli scrittori di opzioni sono più esposti verso la scadenza.
Istantanea di open interest, volume e volatilità implicita per la scadenza scansionata più vicina — contesto, non un segnale di trading.
Insider trading su RGNX (SEC Form 4)
Operazioni degli insider sul mercato aperto relative a RGNX negli ultimi sei mesi circa, tratte dalle comunicazioni SEC Form 4. Gli acquisti sul mercato aperto sono il segnale più raro e più forte — le vendite di routine effettuate nell'ambito di piani prestabiliti sono frequenti, quindi leggi un dato di vendita netta tenendolo presente.
| Insider | Azione | Azioni | Valore | Data |
|---|---|---|---|---|
| PAKOLA STEVE | Vendita | 2161 | $29K | 2026-07-02 |
| PAKOLA STEVE | Vendita | 36.725 | $472K | 2026-07-01 |
| PAKOLA STEVE | Vendita | 19.608 | $216K | 2026-06-29 |
| PAKOLA STEVE | Vendita | 15.309 | $169K | 2026-05-11 |
| PAKOLA STEVE | Vendita | 5124 | $53K | 2026-03-10 |
Fonte: comunicazioni SEC Form 4 tramite Finnhub. Solo acquisti (P) e vendite (S) sul mercato aperto — assegnazioni, esercizi di opzioni, donazioni e ritenute fiscali sono esclusi. Contesto informativo, non consulenza sugli investimenti.
Liquidity and tradeability
RGNX options are thinly traded, with wide bid-ask spreads around 30,5% near the money that eat into any edge — favour simple single-leg or tight defined-risk trades, and always use limit orders.
Earnings & IV crush
RGNX's next earnings report is due around 6 agosto 2026. Options that expire after it price in a binary move, so their implied volatility is elevated and usually collapses right after the announcement — an "IV crush". If your expiration falls before this date, the trade sidesteps the event.
With earnings roughly 15 days out, RGNX's 113% implied volatility is inflated by event premium — and it usually collapses the moment results drop ("IV crush"). That rewards defined-risk premium sellers when the move stays muted, and punishes option buyers who paid the inflated price. Keep size small and risk defined through the report.
Key figures
- Market cap
- $653M
- Beta (vs market)
- 0.90
- 52-week range
- $5.46–$16.19 (44% up the range)
- Short interest
- 21.8% of float · 4.5 days to cover
With 21.8% of RGNX's float sold short, squeeze and gap risk are elevated — one reason its options can stay expensive.
Other strong setups for RGNX
If your view on RGNX differs, these also scored well in the latest scan:
How to choose an options strategy for RGNX
Start with your outlook on RGNX, then match it to a defined-risk structure. Here are the most common choices and when each makes sense:
Bullish
Buy a call for leverage with capped risk, or a bull call spread to lower the cost and breakeven when you have a target price.
Long Call → Bull Call Spread →Bearish
Buy a put to profit from a decline with defined risk, or a bear put spread to cheapen the trade when you expect a measured move down.
Long Put → Bear Put Spread →Neutral
Sell an iron condor to collect premium while RGNX stays between two strikes, or write a covered call against shares you already own.
Iron Condor → Covered Call →⧉ Embed this free calculator on your site →
How we pick the best strategy
For each ticker we pull the live option chain, build every supported strategy around the at-the-money strikes, and score them on probability of profit, risk/reward and capital efficiency — favouring defined-risk structures where the maximum loss is known up front. Methodology →
Open RGNX in the free calculator →
Domande frequenti
What is the best options strategy for RGNX?
It depends on your outlook. Bullish traders often use a long call or bull call spread on RGNX; bearish traders a long put or bear put spread; neutral traders an iron condor or covered call. Our live scan above shows the current highest-scoring defined-risk play.
Are RGNX options liquid enough to trade?
REGENXBIO Inc. (RGNX) is among the most actively-traded US options, which usually means tight bid/ask spreads and plenty of strikes and expirations — though you should always check the open interest and spread on the exact contract.
How much money do I need to trade RGNX options?
Buying a single RGNX call or put can cost as little as the premium (often one to a few hundred dollars), while income strategies like a cash-secured put need enough capital to buy 100 shares if assigned.
Is this financial advice?
No. Everything here is educational and uses delayed, third-party data. It is not a recommendation to trade RGNX or any security. Do your own research.
Cosa fa REGENXBIO Inc.?
REGENXBIO Inc. (RGNX) opera nel settore Biotechnology. La sezione "Informazioni su REGENXBIO Inc." qui sopra offre un quadro più completo di ciò che fa l'azienda e di come genera profitti.
REGENXBIO Inc. paga dividendi?
Qui non mostriamo un rendimento da dividendo confermato per REGENXBIO Inc., quindi consideralo incerto: prima di scrivere delle call controlla il dividendo attuale e la data di stacco cedola (ex-dividend) presso il tuo broker — una data di stacco imminente può innescare un'assegnazione anticipata sulle call scritte in-the-money.
Quando REGENXBIO Inc. pubblica gli utili?
I prossimi utili di REGENXBIO Inc. sono attesi intorno al 6 agosto 2026. La volatilità implicita di solito sale in avvicinamento alla pubblicazione e crolla bruscamente dopo (IV crush) — un aspetto importante per qualsiasi posizione in opzioni che mantieni oltre quella data.
Tickers related to RGNX
Comparing RGNX with similar names can help you choose the best options strategy:
Informazioni sull’azienda
- Sede
- 9804 Medical Center Drive, Rockville, MD, 20850, United States
- Settore
- Biotechnology
- Dipendenti
- 371
- CEO
- Mr. Curran M. Simpson M.S.
- Telefono
- 240 552 8181
- Sito web
- www.regenxbio.com
Best Options Strategy by Ticker →
Solo per uso didattico. Le quotazioni sono ritardate di circa 15 minuti e nulla di ciò che è riportato qui è consulenza finanziaria. Il trading di opzioni comporta un rischio sostanziale di perdita. Privacy · Terms.